e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Airway physiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - A key endpoint in viral challenge models of asthma exacerbations
M. Ghebre (London, United Kingdom), A. Bell (London, United Kingdom), A. Mann (London, United Kingdom)
Source:
International Congress 2019 – Airway physiology
Session:
Airway physiology
Session type:
Poster Discussion
Number:
347
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Ghebre (London, United Kingdom), A. Bell (London, United Kingdom), A. Mann (London, United Kingdom). Late Breaking Abstract - A key endpoint in viral challenge models of asthma exacerbations. 347
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Late Breaking Abstract: An animal model for studies on pathogenesis and pharmaceutical intervention of chronic asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Late Breaking Abstract - Estimating the relationship between environmental exposures and acute exacerbations of COPD
Source: Virtual Congress 2021 – Occupational COVID-19 and respiratory infections
Year: 2021
Late Breaking Abstract - Increased type 2 inflammation in patients with asthma post rhinovirus infection
Source: International Congress 2018 – New pharmacological strategies in airway diseases
Year: 2018
CompEx – A novel composite asthma exacerbation endpoint
Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD
Year: 2015
Childhood asthma and infection: virus-induced exacerbations as determinants and modifiers
Source: Eur Respir J 2010; 36: 438
Year: 2010
Late Breaking Abstract - Reimbursement for asthma care is a universal barrier to achieving asthma symptom control: the SABINA III study
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Late Breaking Abstract - Exacerbation of asthma in childhood: seasonal pattern and risk factors.
Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities
Year: 2017
Late Breaking Abstract - ENose based phenotyping of newly presented patients with asthma or COPD
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018
Late Breaking Abstract - Effects of tezepelumab on host epithelial tolerance to virus in patients with uncontrolled asthma
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021
Late Breaking Abstract - Shared genetic origins of obesity and poor ICS response in children with asthma
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021
Late Breaking Abstract - Azithromycin for acute COPD exacerbations requiring hospitalization – the BACE trial results
Source: International Congress 2018 – Clinical trials in COPD: new results
Year: 2018
Late Breaking Abstract - Microbiome-driven clusters in severe asthma derived from induced sputum: identification and stability over time.
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019
Late Breaking Abstract - Silent exacerbations: underreporting of COPD exacerbations in Poland
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
Late Breaking Abstract - Mepolizumab reduces exacerbations in eosinophilic COPD
Source: International Congress 2017 – Late-breaking studies in asthma and COPD
Year: 2017
Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma.
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Late Breaking Abstract - Clinical characteristics and lung function trends of severe eosinophilic asthma patients unresponsive to Mepolizumab
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019
Late Breaking Abstract - Corticosteroid optimisation in severe asthma using composite biomarkers to adjust dose versus a symptom/risk-based algorithm
Source: Virtual Congress 2020 – ALERT: Asthma in adults and children
Year: 2020
Late Breaking Abstract - Association between blood eosinophils and exacerbation risk in COPD primary care
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Late Breaking Abstract - Cardiovascular adverse events of drugs targeting IL-5 in severe asthma: a pharmacovigilance study
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020
Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept